Simranjit Singh

Sim Singh is a Scientist 1 in Discovery Biology and Target Validation at Rezo. Prior to joining Rezo, Sim worked as a Research Scientist at Arvinas.

Sim was trained as a cancer biologist, focusing on genetic and metabolic mechanisms of drug resistance in glioblastoma. Sim received a B.A. in Economics from New York University and a Ph.D. in Experimental Pathology/Cancer Biology from Duke University School of Medicine.

Outside of the lab, Sim enjoys playing basketball, rock climbing, and podcasting.